Anti-leukotrienes for asthma

Research output: Contribution to journalReview article

11 Scopus citations


The field of cysteinyl leukotriene research has moved forward considerably in the past two years. Significant recent advances have been made in three areas: genetic control of the cysteinyl leukotriene response, in which alterations in both the promoter region and in transcribed mRNA have been described; the mechanisms by which cysteinyl leukotrienes promote the development of inflammation; and extensions in the clinical arena that support broader positioning of leukotriene modifiers in the therapy of asthma and allergic diseases.

Original languageEnglish (US)
Pages (from-to)230-234
Number of pages5
JournalCurrent Opinion in Pharmacology
Issue number3
StatePublished - Jun 1 2001
Externally publishedYes


  • Cysteinyl leukotrienes
  • Eosinophils
  • Genetics
  • Immunology
  • Leukotriene modifiers
  • Molecular Medicine
  • Pharmacology

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Anti-leukotrienes for asthma'. Together they form a unique fingerprint.

  • Cite this